全文获取类型
收费全文 | 348105篇 |
免费 | 31636篇 |
国内免费 | 10734篇 |
专业分类
耳鼻咽喉 | 3594篇 |
儿科学 | 7485篇 |
妇产科学 | 4456篇 |
基础医学 | 27982篇 |
口腔科学 | 8135篇 |
临床医学 | 32141篇 |
内科学 | 47752篇 |
皮肤病学 | 2986篇 |
神经病学 | 13354篇 |
特种医学 | 10970篇 |
外国民族医学 | 123篇 |
外科学 | 35200篇 |
综合类 | 59810篇 |
现状与发展 | 37篇 |
一般理论 | 28篇 |
预防医学 | 36596篇 |
眼科学 | 2858篇 |
药学 | 33283篇 |
485篇 | |
中国医学 | 35756篇 |
肿瘤学 | 27444篇 |
出版年
2024年 | 1390篇 |
2023年 | 6799篇 |
2022年 | 12620篇 |
2021年 | 16506篇 |
2020年 | 15877篇 |
2019年 | 16445篇 |
2018年 | 14902篇 |
2017年 | 13943篇 |
2016年 | 13573篇 |
2015年 | 12801篇 |
2014年 | 23335篇 |
2013年 | 23346篇 |
2012年 | 20752篇 |
2011年 | 22910篇 |
2010年 | 18726篇 |
2009年 | 16190篇 |
2008年 | 15304篇 |
2007年 | 15820篇 |
2006年 | 14128篇 |
2005年 | 11969篇 |
2004年 | 9760篇 |
2003年 | 8474篇 |
2002年 | 6726篇 |
2001年 | 5843篇 |
2000年 | 4981篇 |
1999年 | 4060篇 |
1998年 | 3444篇 |
1997年 | 3175篇 |
1996年 | 2656篇 |
1995年 | 2444篇 |
1994年 | 2282篇 |
1993年 | 1900篇 |
1992年 | 1809篇 |
1991年 | 1580篇 |
1990年 | 1387篇 |
1989年 | 1277篇 |
1988年 | 1216篇 |
1987年 | 1059篇 |
1986年 | 964篇 |
1985年 | 2376篇 |
1984年 | 2639篇 |
1983年 | 1700篇 |
1982年 | 2183篇 |
1981年 | 1610篇 |
1980年 | 1435篇 |
1979年 | 1282篇 |
1978年 | 1060篇 |
1977年 | 834篇 |
1976年 | 917篇 |
1975年 | 612篇 |
排序方式: 共有10000条查询结果,搜索用时 312 毫秒
71.
72.
Christopher Teng JiaDe Yu Jesse Taylor Adam I. Rubin James R. Treat 《Pediatric dermatology》2019,36(5):697-701
Erosive pustular dermatosis of the scalp (EPDS) is an uncommon chronic inflammatory response to scalp trauma that usually resolves with cicatricial alopecia. It most commonly affects elderly patients with a history of actinic damage. Herein, we describe a 16‐year‐old girl with acrofacial dysostosis type 1 presenting after surgery with crusting purulent scalp lesions, whose clinical presentation and histopathologic findings were consistent with EPDS. A review of the literature on EPDS in children is also detailed. 相似文献
73.
Whitney S. Brandt Wanpu Yan Jian Zhou Kay See Tan Joseph Montecalvo Bernard J. Park Prasad S. Adusumilli James Huang Matthew J. Bott Valerie W. Rusch Daniela Molena William D. Travis Mark G. Kris Jamie E. Chaft David R. Jones 《The Journal of thoracic and cardiovascular surgery》2019,157(2):743-753.e3
Objective
Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.Methods
Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.Results
In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.Conclusions
Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection. 相似文献74.
75.
76.
77.
B Maybury A Powell-Chandler N Kumar 《Annals of the Royal College of Surgeons of England》2015,97(3):e37-e38
We report two British cases of liver abscess, due to Klebsiella pneumoniae and associated with synchronous infection elsewhere, which required liver resection for definitive treatment. They illustrate the geographic spread of aggressive K pneumoniae liver infection and demonstrate the importance of early aggressive treatment. 相似文献
78.
目的:探讨3D-CRT 低剂量区 V5体积的大小对非小细胞肺癌患者肺功能的影响。方法:收集我院肿瘤科2014年4月~2015年10月收治的46例首次行三维适形放射治疗且顺利完成治疗的非小细胞肺癌患者,对每例患者分别在治疗前以及治疗后的1、3个月进行肺功能检测,分析3D-CRT 低剂量区 V5体积的大小与肺功能变化之间的关系。结果:放疗后1个月的 FEV1%、FVC%值明显高于放疗前且差异均具有显著性。放疗后1个月、3个月的 DLCO%值明显低于放疗前,且放疗前的与放疗后3个月的差异具有显著性;V5≦45%、45%55%三组放疗前后的 FEV1%值和 FVC%值比较差异均不具有显著性。V5≦45%、45%55%三组放疗前后的 DLCO%值均呈逐渐下降趋势,且 V5>55%组的放疗前后 DLCO%值比较差异具有显著性。而 V5≦45%组和45%55%时,DLCO%值降低的趋势更加显著。 相似文献
79.
80.
John Bickle 《Topics in Cognitive Science》2015,7(2):299-311
David Marr's three-level method for completely understanding a cognitive system and the importance he attaches to the computational level are so familiar as to scarcely need repeating. Fewer seem to recognize that Marr defends his famous method by criticizing the “reductionistic approach.” This sets up a more interesting relationship between Marr and reductionism than is usually acknowledged. I argue that Marr was correct in his criticism of the reductionists of his time—they were only describing (cellular activity), not explaining (cognitive functions). But a careful metascientific account of reductionistic neuroscience over the past two decades reveals that Marr's criticisms no longer have force. Contemporary neuroscience now explains cognition directly, although in a fashion—causal-mechanistically—quite different than Marr recommended. So while Marr was correct to reject the reductionism of his day and offer an alternative method for genuinely explaining cognition, contemporary cognitive scientists now owe us a new defense of Marr's famous method and the advantages of its explanations over the type now pursued successfully in current reductionist neuroscience. There are familiar reasons for thinking that this debt will not be paid easily. 相似文献